GemCyclo Bio Overview
GemCyclo Bio is an early-stage bio-pharmaceutical company holding a library of novel orally available cyclic peptides targeting validated molecular pathways of immune and inflammatory diseases (I&I), Cancer, and metabolic diseases. The innovative new drugs are licensed from the Hebrew University of Jerusalem and designed and synthesized by Prof Chaim Gilon and his colleagues with the proprietary Cycloscan technology, rapidly achieving orally available small cyclic peptides which are highly potent and metabolically stable, enabling multiple routes of administration. The novel GemCyclo Bio cyclic peptides embrace the best of small molecules and of larger protein drugs; they are easy to synthesize and of low immunogenicity as small molecules, and of highest affinity and selectivity to target active site as monoclonal antibodies (mAbs), and low off-target toxicity, all at the same time in one novel cyclic peptide molecule.
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
2
Employees: 1-10
Web & Social Links
Locations
Jerusalem, Israel
Photos & Videos
No files yet
GemCyclo Bio Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
BiologicalsMoleculesTags (6)
drug-discoveryautoimmune-diseasesinflammatory-diseasesmetabolic-diseasepeptidescancerGemCyclo Bio Financials
GemCyclo Bio Lifecycle
GemCyclo Bio News
0 articlesNo news articles.
GemCyclo Bio Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 5 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
GemCyclo Bio Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 75/100 |
| Missing | sector, homepage, video or image, funding rounds, news, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wainscheinker@sncentral.org |
| Last update | 2025-08-28T00:00:00.000Z |
| Created | 2025-08-28T00:00:00.000Z |